Application of the Latest Therapeutic Strategies to Treat Acute Lymphoblastic Leukemia

Review the latest data and expert recommendations on incorporating emerging therapeutic strategies into the care of patients with ALL. This comprehensive program includes an Interactive Decision Support Tool, expert commentaries, and an expert-authored module with downloadable slideset.
Daniel J. DeAngelo, MD, PhD
Elias Jabbour, MD
person default
Aaron C. Logan, MD, PhD
Jae H. Park, MD
Eunice S. Wang, MD

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with ALL with those of 5 renowned experts.

Daniel J. DeAngelo, MD, PhD Elias Jabbour, MD person default Aaron C. Logan, MD, PhD Jae H. Park, MD Eunice S. Wang, MD Released: April 21, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Amgen
Jazz Pharmaceuticals, Inc.
Pfizer Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?